Table 2 Major research advances in ncRNA and HIF-1α in cancer
ncRNAs |
Cancer |
Regulatory mechanisms |
Functions |
Ref. |
miRNA |
||||
miR-671-5p |
Oophoroma |
Inhibiting HIF-1α expression via activating HDAC5 |
Proliferation and apoptosis |
|
miR-29a |
HCC |
Supressing HIF-1α expression |
Proliferation |
|
miR-142-3p |
HCC |
Inhibiting PI3K/AKT/HIF-1α signaling |
Invasion and apoptosis |
|
miR-138-5p |
HCC |
Targeting HIF-1α and regulating its expression |
Vascular mimicry |
|
miR-322/424 |
Cirrhosis |
Inducing HIF-1α protein expression |
Angiogenesis and migration |
|
miR-200c |
HCC |
Downregulating the transcriptional activity of HIF-1α |
||
lncRNA |
||||
LINC00649 |
Breast cancer |
Maintaining the stability of HIF-1α |
Metastasis |
|
NORAD |
Colorectal cancer |
Acting as miR-495-3p sponge to adjust HIF-1α |
Angiogenesis and chemotherapy resistance |
|
FAM83A-AS1 |
Lung adenocarcinoma |
Suppressed combination of HIF-1α and VHL leads to HIF-1α accumulation |
Proliferation and migration |
|
LINC00525 |
Colorectal cancer |
Activating HIF-1α via miR-338-3p/UBE2Q1/β-catenin axis |
Proliferation |
|
PAARH |
HCC |
Promoting HIF-1α/VEGF signaling |
Progression and angiogenesis |
|
HIFAL |
Breast cancer |
Enhancing HIF-1α transactivation |
Proliferation |
|
MAPKAPK5-AS1 |
HCC |
Adjusting HIF-1α expression via PLAGL2 |
Progression |
|
circRNA |
||||
circ_03955 |
Pancreatic cancer |
Promoting HIF-1α through sponging miR-3662 expression |
Tumorigenesis and Warburg effect |